PMV Pharmaceuticals
PMVP
PMVP
106 hedge funds and large institutions have $324M invested in PMV Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-5
Holders Change %
-4.5%
% of All Funds
1.67%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
18
Increased
40
Reduced
29
Closed
23
Calls
$121K
Puts
$21K
Net Calls
+$100K
Net Calls Change
+$38K
Top Buyers
| 1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$4.44M |
| 2 |
2
BlackRock
New York
|
$29.3M |
| 3 |
WP
3
Woodline Partners
San Francisco,
California
|
$4.59M |
| 4 |
OCA
4
Octagon Capital Advisors
New York
|
$2.94M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$13.3M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
S
126
SignatureFD
Atlanta,
Georgia
| – | -$2.1K | -440 | Closed |
|
127
US Bancorp
Minneapolis,
Minnesota
| – | -$1.77K | -370 | Closed |
|
|
RTL
128
Red Tortoise LLC
Atlanta,
Georgia
| – | -$1.1K | -230 | Closed |
|
|
AF
129
Allworth Financial
Folsom,
California
| – | -$187 | -39 | Closed |
|